ABBV-154

N/A

Report date: 2024/10/09 20:00:32

Base Information

Drug NameABBV-154
Drug Alias NameABBV-154
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)
Mechanisms of ActionImmunomodulatorsGlucocorticoid receptor modulatorsTumor necrosis factor inhibitors
TargetsTumor necrosis factorGlucocorticoid receptor
Therapy Area/IndicationsInflammationCrohn DiseaseArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBelgiumBulgaria +[27] 
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesAbbvie Inc
China Registration ClassN/A

Develop Information

Active CompaniesAbbvie Inc
Inactive CompaniesN/A
Active IndicationsInflammation
Inactive IndicationsCrohn DiseaseArthritis, Rheumatoid

Other Information

ATC CodeN/A
Related LinksN/A